K
Kelly A. Avery-Kiejda
Researcher at University of Newcastle
Publications - 47
Citations - 1489
Kelly A. Avery-Kiejda is an academic researcher from University of Newcastle. The author has contributed to research in topics: Breast cancer & Triple-negative breast cancer. The author has an hindex of 17, co-authored 41 publications receiving 1234 citations. Previous affiliations of Kelly A. Avery-Kiejda include John Hunter Hospital.
Papers
More filters
Journal ArticleDOI
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.
Clare Stirzaker,Elena Zotenko,Jenny Z. Song,Wenjia Qu,Shalima S. Nair,Warwick J. Locke,Andrew Stone,Nicola J. Armstong,Mark D. Robinson,Alexander Dobrovic,Kelly A. Avery-Kiejda,Kate M. Peters,Juliet D. French,Sandra Stein,Darren Korbie,Matt Trau,John F. Forbes,Rodney J. Scott,Melissa A. Brown,Glenn Francis,Susan J. Clark +20 more
TL;DR: The data reveal that coordinated hypermethylation can occur in oestrogen receptor-negative disease, and that characterizing the epigenetic framework provides a potential signature to stratify TNBCs, demonstrating the feasibility of profiling the cancer methylome with limited archival tissue to identify regulatory regions associated with cancer.
Journal ArticleDOI
Up-regulation of Mcl-1 Is Critical for Survival of Human Melanoma Cells upon Endoplasmic Reticulum Stress
Chen Chen Jiang,K. M. Lucas,Kelly A. Avery-Kiejda,Margaret Wade,Charles E. deBock,Rick F. Thorne,John F. Allen,Peter Hersey,Xudong Zhang +8 more
TL;DR: The mechanisms of resistance of melanoma cells to apoptosis induction mediated by BH3-only proteins upon ER stress are revealed, and Mcl-1 is identified as a target for the treatment of melanomas in combination with therapeutics that induce ER stress.
Journal ArticleDOI
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Kelly A. Avery-Kiejda,Xudong Zhang,Luke J. Adams,Rodney J. Scott,Borivoj Vojtesek,David P. Lane,Peter Hersey +6 more
TL;DR: It is reported that p53β and Δ40p53 were expressed in the majority of melanoma cell lines at the mRNA level, but were absent or expressed at low levels in fibroblasts and melanocytes, suggesting that their expression may play a role in melanoma development.
Journal ArticleDOI
BRIP1 , PALB2 , and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer
Michelle W. Wong,Cecilia Nordfors,David Mossman,Gordana Pecenpetelovska,Kelly A. Avery-Kiejda,Bente A. Talseth-Palmer,Nikola A. Bowden,Rodney J. Scott,Rodney J. Scott +8 more
TL;DR: This study supports recent observations that although rare, PALB2 mutations are present in a small but substantial proportion of inherited breast cancer cases, and indicates that RAD51C at a population level does not account for a substantial number of familial Breast cancer cases.
Journal ArticleDOI
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
Kelly A. Avery-Kiejda,Nikola A. Bowden,Amanda Croft,Lyndee L. Scurr,Carla F. Kairupan,Katie A. Ashton,Bente A. Talseth-Palmer,Helen Rizos,Xu D. Zhang,Rodney J. Scott,Peter Hersey +10 more
TL;DR: It is indicated that P53 target genes involved in apoptosis and cell cycle regulation are aberrantly expressed in melanoma and that this aberrant functional activity of P53 may contribute to the proliferation of melanoma.